YESAFILI 40 mg/ml sol inj flac perf 1 pce

7680702110011 CH-70211 S01LA05 11.99.0.

Active substances:

Afliberceptum

No images available

Details

Product number
7021101
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
afliberceptum 2 mg, histidinum, histidini hydrochloridum monohydricum, polysorbatum 20, trehalosum dihydricum, aqua ad iniectabile, ad solutionem pro 0.05 ml.

Articles (1)

Yesafili 40 mg/ml, Injektionslösung
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
afliberceptum
2.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
trehalosum dihydricum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
70211
Drug name
Yesafili, Injektionslösung
Galenic form
LSINJ
ATC Code
S01LA05
Authorization status
Z
Dispensation category
B
First authorization
05/09/2025
Authorization expiration date
04/09/2030
IT number
11.99.0.
Domain
Human medicine
Field of application
Exsudative (feuchte) altersbezogenen Makuladegeneration (AMD). Makulaödem infolge eines retinalen Zentralvenenverschlusses (CRVO) und retinalen Venenastverschlusses (BRVO), diabetisches Makulaödem (DME), Behandlung von subfovealen und juxtafovealen choroidalen Neovaskularisationen infolge einer pathologischen Myopie (mCNV).

Packaging details

Description (FR)
YESAFILI 40 mg/ml sol inj flac perf 1 pce
Description (DE)
YESAFILI 40 mg/ml Inj Lös Durchstf 1 Stk
Market launch
01/04/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data